HealthSTAT News
STAT+: Alnylam defends heart disease drugs after failure of AstraZeneca’s Wainua
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
An AstraZeneca heart disease trial failure has put Alnylam under pressure. It's mounting a defense of its medicines.
Join the argument
House rules →Comments load as you scroll.